Novo A/S as of March 31, 2016
Portfolio Holdings for Novo A/S
Novo A/S holds 17 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF (VTI) | 32.6 | $297M | 2.8M | 104.82 | |
| Ophthotech | 22.8 | $208M | 4.9M | 42.27 | |
| Inogen (INGN) | 17.5 | $160M | 3.5M | 44.98 | |
| Vanguard European ETF (VGK) | 11.2 | $102M | 2.1M | 48.52 | |
| Corvus Pharmaceuticals (CRVS) | 5.0 | $46M | 3.2M | 14.50 | |
| Colucid Pharmaceuticals | 2.1 | $19M | 3.1M | 6.20 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 2.0 | $19M | 2.3M | 8.18 | |
| Acceleron Pharma | 1.9 | $18M | 673k | 26.39 | |
| Penumbra (PEN) | 1.3 | $12M | 263k | 46.00 | |
| Nabriva Therapeutics | 0.9 | $7.8M | 875k | 8.96 | |
| Invuity | 0.7 | $6.8M | 936k | 7.22 | |
| Wright Medical Group Rtsn V | 0.6 | $5.8M | 4.6M | 1.25 | |
| Htg Molecular Diagnostics | 0.4 | $3.7M | 1.3M | 2.87 | |
| Spectranetics Corporation | 0.4 | $3.4M | 237k | 14.52 | |
| Tokai Pharmaceuticals | 0.3 | $2.6M | 471k | 5.61 | |
| Glaukos (GKOS) | 0.2 | $1.7M | 101k | 16.86 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $892k | 128k | 6.99 |
